Fukuda Denshi Co (6960.T) Stock Price
Fukuda Denshi Co Price
Fukuda Denshi Co (6960.T) Stock | ISIN JP3806000000. The current Fukuda Denshi Co stock price is 11,400 JPY (2026). Revenue is 143.75 B JPY. Net income is 23.7 B JPY. The P/E ratio is 13.87. Market capitalization is 430.35 B JPY. Fukuda Denshi Co operates in the Health sector.
Fukuda Denshi Co stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Fukuda Denshi Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Fukuda Denshi Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Fukuda Denshi Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Fukuda Denshi Co Price |
|---|
Fukuda Denshi Co Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Fukuda Denshi Co Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (M JPY) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (M JPY) |
| NET INCOME (M JPY) |
| NET INCOME GROWTH (%) |
| DIVIDEND (JPY)DIV. (JPY) |
| DIVIDEND GROWTH (%)DIV. GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Fukuda Denshi Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Fukuda Denshi Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Fukuda Denshi Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Fukuda Denshi Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Fukuda Denshi Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Fukuda Denshi Co stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Fukuda Denshi Co Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Fukuda Denshi Co business model & stock analysis
Fukuda Denshi Co SWOT Analysis
Strengths
Fukuda Denshi Co Ltd possesses several strengths that contribute to its success:
- Established brand with a strong reputation in the healthcare industry.
- Wide range of innovative and high-quality medical devices.
- Extensive distribution network, both domestic and international.
- Strong financial position and stable revenue growth.
- Strong research and development capabilities, driving continuous product improvement.
- Dedicated and skilled workforce with expertise in healthcare technology.
Weaknesses
There are certain weaknesses that Fukuda Denshi Co Ltd should address:
- Relatively high manufacturing costs compared to some competitors.
- Dependency on key suppliers for certain components.
- Limited presence in emerging markets with significant growth potential.
- Need for more effective marketing and brand awareness strategies.
- Limited diversification of its product portfolio.
Opportunities
Fukuda Denshi Co Ltd can leverage the following opportunities:
- Rising healthcare expenditure globally, presenting an expanding market.
- Growing demand for remote patient monitoring solutions.
- Increasing adoption of digital healthcare technologies.
- Emerging opportunities in developing countries with underdeveloped healthcare systems.
- Potential partnerships and collaborations with other healthcare companies.
- Exploring acquisitions to strengthen and diversify its product portfolio.
Threats
Fukuda Denshi Co Ltd should be aware of the following threats:
- Intense competition from global and local medical device manufacturers.
- Regulatory challenges and compliance requirements in various markets.
- Rapid technological advancements and the need to stay ahead of competitors.
- Potential economic downturns affecting healthcare spending.
- Geopolitical instability and trade barriers impacting international operations.
Fukuda Denshi Co Eulerpool Fair Value
Fukuda Denshi Co historical P/E ratio, EBIT multiple, and P/S ratio
Fukuda Denshi Co annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Fukuda Denshi Co shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Fukuda Denshi Co Dividend History
38 years of dividend payments · 2 consecutive increases
Fukuda Denshi Co dividend history and estimates
Max
Details
Fukuda Denshi Co dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Fukuda Denshi Co shareholder structure
| % | Name |
|---|---|
7.94702% | |
7.19683% | |
3.98675% | |
3.68212% | |
3.5894% | |
3.09519% | |
2.76026% | |
2.64901% | |
1.94437% | |
1.61854% |
Fukuda Denshi Co Executives and Management Board
Mr. Kotaro Fukuda
(79)Chairman of the Board, Chief Executive Officer, Representative Director · since 1973
Mr. Daijiro Shirai
(73)President, Chief Operating Officer, Representative Director · since 2006
Mr. Kazuo Genchi
(66)Managing Director, Chief Director of Sales · since 2014
Mr. Naoki Kuno
(56)Managing Director, Manager of President's Office · since 2015
Mr. Haruo Ogawa
(67)Managing Director, Chief Director of Quality Assurance · since 2020
Fukuda Denshi Co Supply Chain
Frequently asked questions about Fukuda Denshi Co
Fukuda Denshi Co Ltd's business model revolves around providing advanced medical and healthcare solutions. As a leading global medical device manufacturer, Fukuda Denshi specializes in the development, production, and distribution of a wide range of medical equipment and systems. The company's extensive product portfolio includes patient monitoring systems, electrocardiographs, defibrillators, ultrasound devices, and more. With a strong emphasis on technological innovation and quality, Fukuda Denshi aims to contribute to the improvement of healthcare worldwide by delivering reliable and efficient medical solutions.
Fukuda Denshi Co stock
Fukuda Denshi Co Peer Group
Fukuda Denshi Co Ticker
Fukuda Denshi Co FIGI
All fundamentals and in-depth analysis of Fukuda Denshi Co
Our stock analysis for Fukuda Denshi Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fukuda Denshi Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.